Suven Life Sciences Limited reported earnings results for the second quarter and six months ended September 30, 2023. For the second quarter, the company reported sales was INR 30.6 million compared to INR 43.87 million a year ago. Revenue was INR 82.01 million compared to INR 45.93 million a year ago. Net loss was INR 126.8 million compared to INR 231.82 million a year ago. Basic loss per share from continuing operations was INR 0.58 compared to INR 1.59 a year ago. Diluted loss per share from continuing operations was INR 0.58 compared to INR 1.59 a year ago.
For the six months, sales was INR 68.57 million compared to INR 79.26 million a year ago. Revenue was INR 176.38 million compared to INR 85.68 million a year ago. Net loss was INR 367.71 million compared to INR 395.08 million a year ago. Basic loss per share from continuing operations was INR 1.69 compared to INR 2.72 a year ago. Diluted loss per share from continuing operations was INR 1.69 compared to INR 2.72 a year ago.